Market Overview

Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target to $19

Related ELN
Perrigo, Elan Receive Irish High Court Approval for Perrigo's Proposed Acquisition of Elan
Perrigo Shareholders Approve Acquisition Of Elan

In a report from Jefferies' Corey Davis published Tuesday, the analyst suggested Elan (NYSE: ELN) execs have indicated they may agree or strongly consider a takeover anywhere between $15 to $20 per share.

Davis's analysis supports a $19/share bid, but only from a "high taxpaying suitor."

Davis named some potential strategic buyers: Allergan (NYSE: AGN), Regeneron (NASDAQ: REGN), Vertex (NASDAQ: VRTX), Alexion (NASDAQ: ALXN), Zoetis (NYSE: ZTS), Mylan (NASDAQ: MYL), and Perrigo (NYSE: PRGO)n

Jefferies maintains a Buy rating; the price target was raised from $14 to $19.

The stock is up 2 percent to $13.76 in early-morning trade.

Latest Ratings for ELN

Jul 2013JefferiesDowngradesBuyHold
Jun 2013JefferiesMaintainsBuy
Feb 2013Leerink SwannUpgradesUnderperformMarket Perform

View More Analyst Ratings for ELN
View the Latest Analyst Ratings

Posted-In: Analyst Color News Price Target M&A Analyst Ratings


Related Articles (ALXN + AGN)

View Comments and Join the Discussion!

Partner Center